Comparison of Coapsys annuloplasty and internal reduction mitral annuloplasty in the randomized treatment of functional ischemic mitral regurgitation: Impact on the left ventricle  by Grossi, E.A. et al.
C
m
f
l
E
J
Grossi et al Surgery for Acquired Cardiovascular Diseaseomparison of Coapsys annuloplasty and internal reduction
itral annuloplasty in the randomized treatment of
unctional ischemic mitral regurgitation: Impact on the
eft ventricle
. A. Grossi, MD,a Y. J. Woo, MD,b C. F. Schwartz, MD,a D. M. Gangahar, MD,c V. A. Subramanian, MD,d N. Patel, MD,d. Wudel, MD,e P. L. DiGiorgi, MD,a A. Singh, MD,f and R. D. Davis, MDg
B
v
g
T
r
M
a
a
(
I
a
r
e
p
R
a
2
0
d
(
L
m
d
4
0
C
f
s
F
g
F
t
t
A
CDFrom New York University School of Med-
icine and Veterans Administration NY Har-
bor Healthcare System, New York, NYa;
Hospital of the University of Pennsylvania,
Philadelphia, Pab; University of Nebraska
Medical Center, Omaha, Nebc; Lenox Hill
Hospital, New York, NYd; Nebraska Heart
Institute, Lincoln, Nebe; Rhode Island Hos-
pital, Providence, RIf; and Duke University
School of Medicine, Durham, NC.g
Read at the Thirty-first Annual Meeting
of The Western Thoracic Surgical Asso-
ciation, Victoria, BC, Canada, June 22-
25, 2005.
Received for publication June 23, 2005;
revisions received Nov 8, 2005; accepted
for publication Nov 29, 2005.
Address for reprints: Eugene A. Grossi,
MD, NYU Medical Center, Suite 9-V, 530
First Ave, New York, NY 10028 (E-mail:
grossi@cv.med.nyu.edu).
J Thorac Cardiovasc Surg 2006;131:1095-8
0022-5223/$32.00
Copyright © 2006 by The American Asso-
ciation for Thoracic Surgeryd
doi:10.1016/j.jtcvs.2005.11.046
Tackground: Functional mitral regurgitation is associated with both annular and
entricular distortion. Aggressive reduction annuloplasty for functional mitral re-
urgitation acts primarily at the annulus, with variable impact on the left ventricle.
he Coapsys device externally reshapes the left ventricle to correct functional mitral
egurgitation. Left ventricular reshaping was analyzed in a randomized study.
ethods: The RESTOR-MV study randomizes patients with coronary artery disease
nd functional mitral regurgitation to either reduction annuloplasty and coronary
rtery bypass grafting (the RA group) or Coapsys annuloplasty and bypass grafting
the CO group). The Coapsys device consists of epicardial pads connected by a cord.
t was placed without cardiopulmonary bypass under echocardiographic guidance
nd sized to reduce annular dimension and improve leaflet coaptation. Internal
eduction annuloplasty was performed by device placement. Intraoperative trans-
sophageal echocardiograms were analyzed in 7 patients having reduction annulo-
lasty and 7 having Coapsys annuloplasty.
esults: Baseline mitral regurgitation (0-4 scale) was similar for the RA (3.0  0.6)
nd the CO groups (3.0 0.6). Intraoperative mitral regurgitation was reduced from
.86  0.7 to 0.5  0.7 (P  .01 pre vs post) for the RA group and from 2.64 
.9 to 05  0.7 (P  .01 pre vs post) for the CO group. Annular anteroposterior
iameter was reduced with both techniques: RA, 3.45  0.39 to 2.34  0.37 cm
P  .01 pre vs post); CO, 3.40  0.27 to 2.85  0.34 cm (P  .05 pre vs post).
ong-axis dimensions were unchanged with both techniques. Short-axis dimensions
easured at three levels were significantly reduced only in the CO patients: basal
iameter 4.77  0.58 to 3.58  0.38 cm (P  .01 pre vs post); mid diameter
.88  0.55 to 3.57  0.43 cm (P  .01 pre vs post); and apical diameter 4.39 
.46 to 3.38  0.34 cm (P  .01 pre vs post).
onclusions: Coapsys and reduction annuloplasty techniques both acutely reduce
unctional mitral regurgitation and annular dimension. The Coapsys device provided
ignificantly greater left ventricular reshaping than did reduction annuloplasty.
urther evaluation will assess the long-term valvular function and ventricular
eometric stability associated with both techniques.
unctional ischemic mitral insufficiency is a ventricular disease characterized by a
combination of annular enlargement and subvalvular displacement.1,2 Although
internal reduction annuloplasty treats the annular component, this technique fails
o affect the subvalvular component. Several proponents of functional mitral regurgi-
ation repair suggest that in some patients, the localized subvalvulvar ventricular
istortion is so advanced that aggressive undersizing annuloplasty alone is inadequate
he Journal of Thoracic and Cardiovascular Surgery ● Volume 131, Number 5 1095
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A
CDor producing a durable result.3,4 The advent of directed ven-
ricular shape change technology offers the surgeon the oppor-
unity to treat functional mitral insufficiency by both external
eduction annuloplasty and ventricular reshaping. This study
ompares the intraoperative geometric effects of internal re-
uction annuloplasty and the Coapsys annuloplasty system
Myocor, Inc, Maple Grove, Minn) in the treatment of func-
ional mitral insufficiency.
aterial and Methods
he RESTOR-MV (Randomized Evaluation of a Surgical Treat-
ent for Off-pump Repair of the Mitral Valve) multicenter inves-
igational device exemption (IDE) primary study group random-
zes patients with coronary artery disease and functional mitral
nsufficiency to either coronary artery bypass grafting (CABG)
lus open internal reduction annuloplasty or CABG plus correction
f the mitral insufficiency with the Coapsys device. All investiga-
ive sites had institutional review board approval and all patients
igned informed consent forms to participate in this study. Inclu-
ion and exclusion criteria for study admission have been previ-
usly published.5 The first 7 patients in each study group with
omplete intraoperative echocardiographic data sets are the sub-
ects of this report.
oapsys Device
lthough previously described,5-7 the procedure is briefly detailed
ere. The Coapsys ventricular shape-change device consists of two
picardial pads connected by a flexible suture-like cord (Figure 1).
ith the use of specially designed instruments and epicardial echo-
ardiographic guidance, the cord is passed through the left ventricle
LV) (between the papillary muscles and bisecting the ventricle) and
hen sequentially tightened to improve leaflet coaptation and stabilize
he ventricular wall. The precise placement is accomplished by use of
suction-cup stabilized instrument (jig) with anterior and posterior
ocators. The posterior locator is positioned externally between the
apillary muscle insertions, about 2 cm below the insertion of the
osterior leaflet. The anterior locator is placed on the right ventricular
ide of the left anterior descending coronary artery, about halfway
own the longitudinal axis of the ventricle. These locations are de-
ermined by handheld epicardial echocardiography. This jig then
uides a thin blunt-tipped needle through the LV from one locator to
he other. The needle provides a thin conduit for passage of the
oapsys cord through the ventricle; pads are connected to both ends
f the cord. Sizing is then conducted under real-time color flow
oppler imaging to quantify mitral insufficiency. The cord length is
Abbreviations and Acronyms
CABG  coronary artery bypass grafting
IDE  investigational device exemption
LV  left ventricle (ventricular)
RESTOR-MV Randomized Evaluation of a Surgical
Treatment for Off-pump Repair of the
Mitral Valvehortened and final length is determined by elimination of mitral v
096 The Journal of Thoracic and Cardiovascular Surgery ● Mansufficiency or a maximum shortening of 35%. Although one of the
atients had the CABG performed on pump, all of the Coapsys
eployments were done off pump.
nternal Reduction Mitral Annuloplasty
ggressive internal reduction mitral annuloplasty was accomplished
y implanting an undersized annuloplasty device, a typical reduction
f 1 to 2 sizes. The devices were chosen at the discretion of the
urgeon. Annuloplasty devices implanted included the following: C-G
uture band (26, 28; Medtronic, Inc, Minneapolis, Minn), Carpentier-
dwards Physio Annuloplasty Ring (26, 26; Edwards Lifesciences,
rvine, Calif), Duran (27, 27; Medtronic, Inc), and Séguin Annulo-
lasty Ring (24; St Jude Medical, Inc, St Paul, Minn).
For this study, functional mitral valve regurgitation was defined as
itral valve dysfunction resulting from dilatation of the mitral valve
nnulus, displacement of the LV papillary muscles, chordal tethering
f the mitral valve leaflets, or any combination of these factors. All
atients had concomitant coronary disease requiring revasculariza-
ion. Intraoperative transesophageal echocardiography was used to
cquire long-axis, 2-chamber (septal-lateral), and 4-chamber views
equired to measure geometric changes as well as to quantify
itral regurgitation (0 to 4 scale). The sphericity index was cal-
ulated as the ratio of the dimensions of ventricular short- to
ong-axis dimensions in the long-axis plane. LV volume was
pproximated in diastole from the long-axis views with the use of
Figure 1. Coapsys device.
ABLE 1. RESTOR-MV Study subset patient basic charac-
eristics
Internal reduction
annuloplasty
Coapsys
device
P
value*
7 7 NA
ale (%) 57.1 86 .28
ean age (y) 67.4 7.5 63.3  10 .42
revious MI 4 (57%) 5 (71%) .50
ean no. of grafts 2.71 1.4 2.71  1.1 .99
reop mean LVEF (%) 40.0 9.1 39.4  8.1 .90
reop acute MI (%) 0 0 .99
n pump 7 (100%) 1 (14.3%) .002
perative time (min) 324.4 48.4 314.4 81.7 .78
ospital mortality (%) 0 0 .99
A, Not available; MI, myocardial infarction; LVEF, left ventricular ejection
raction. *Unpaired t test for continuous variables; 2 test for categorical
ariables.
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A
CDstacked disk model. Short-axis diameters were measured at the
nnulus and at 3 equidistant latitudes perpendicular to the long
xis.
esults
he two randomized patient groups were similar with respect
o basic characteristics (Table 1). Intraoperatively, mitral re-
urgitation was reduced from 2.86  0.7 to 0.5  0.7 (P 
01) for reduction annuloplasty and from 2.64  0.9 to 0.5 
.7 (P  .01) for Coapsys annuloplasty. Geometric data and
nalysis are presented in Table 2. Annular anteroposterior
iameter was reduced with both techniques: 3.45 0.39 cm to
.34 0.37 cm (P .01) for reduction annuloplasty and 3.40
0.27 cm to 2.85  0.34 cm (P  .05) for Coapsys annylo-
lasty. The long-axis dimension was unchanged for both re-
uction (7.59  1.17 to 7.8  1.09 cm) and Coapsys annulo-
lasty (8.11 1.08 to 7.78 0.78 cm). Ventricular diameters
easured at the 3 levels were significantly reduced only in the
oapsys patients: basal diameter 4.77  0.58 to 3.58  0.38
m (P .01); mid diameter 4.88 0.55 to 3.57 0.43 cm (P
.01); and apical diameter 4.39  0.46 to 3.38  0.34 cm
P  .01). LV diastolic volume was reduced only in the
oapsys patients. Hemodynamics were similar for both groups
hen quantifying mitral insufficiency at both intraoperative
imes. Figures 2 and 3 represent typical diastolic images before
nd after intervention with both operative strategies.
iscussion
oth surgical approaches, Coapsys annuloplasty and internal
eduction mitral annuloplasty, have initial efficacious results in
ABLE 2. Intraoperative annular and ventricular dimension
Internal redu
Pre
nnular AP diameter (cm) 3.45 0.39
asal diameter (cm) 4.83 1.12
id diameter (cm) 4.84 0.81
pical diameter (cm) 4.06 0.96
V long-axis length (cm) 7.6 1.17
V sphericity (mid diameter/long axis) 0.65 0.12
V volume diastole (mL)† 126.5 62.7
EE, Transesophageal echocardiography; AP, anteroposterior; LV, left venThe Journal of Thoraciche treatment of the mitral insufficiency. The surgical literature
as suggested that the long-term outcome of repair for func-
ional mitral insufficiency is problematic and survival is known
o be poor in these patients.8-10 Importantly, the degree of
re-existing LV dysfunction is not directly associated with the
mount of functional mitral insufficiency.11 Additionally,
hile authors have attempted to show a link between this poor
urvival outcome and the underlying poor LV function in this
opulation,8,12 it is not clear whether or not some of this poor
utcome may be attributable to recurrent mitral insufficiency.13
ertainly some believe that there are very dysplastic ventricles
ith such localized distortion of the subvalvular geometry that
epair is inappropriate. Whether examining baseline leaflet
oaptation distortion3,14 or lateral papillary muscle displace-
ent,4 surgeons are identifying subpopulations based on ven-
ricular distortion in which internal reduction annuloplasty for
unctional ischemic mitral insufficiency has a high likelihood
f failure.
There is experimental evidence that elimination of mitral
nsufficiency does not prevent further deleterious LV remod-
ling.15 Interestingly, the control group will provide informa-
ion as to whether long-term ventricular dimensions stabilize,
mprove, or worsen16 after reduction annuloplasty alone and
hether the acute positive ventricular reshaping effect of the
oapsys device is sustained. Additionally, we may be able to
etermine whether annuloplasty device preference has an im-
act on procedural and long-term outcome.
The Coapsys device is unique in that it not only addresses
he annular distortion but also corrects the ventricular changes
Figure 2. Preoperative (A) and postoperative
(B) echocardiographic views after internal re-
duction mitral annuloplasty. LA, Left atrium; Ao,
aorta.
easured by TEE long axis views
annuloplasty Coapsys implant
Post Pre Post
2.34 0.37* 3.40 0.27 2.85 0.34†
4.93 0.82 4.77 0.58 3.58 0.38*
5.01 0.70 4.88 0.55 3.57 0.43*
4.45 0.69 4.39 0.46 3.38 0.34*
7.8  1.09 8.1  1.08 7.8 0.78
0.63 0.09 0.61 0.08 0.46 0.07†
128.9 35.9 132.7 36.1 91.0 11.5
ar. *P  .01 pre vs post; †P  .05 pre vs post. (Data are mean  SD.)s m
ctionand Cardiovascular Surgery ● Volume 131, Number 5 1097
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A
CDy reshaping the ventricle in the anteroposterior dimension.
his may have several consequences. First, the posterior pads
f the device typically extend apically to the insertion site of
he papillary muscles and place tension in an anterosuperior
irection. This restores the papillary muscles to a more sub-
alvular position, with decreases in the annular to coaptation
oint distances and in the tenting area.5 Second, unlike reduc-
ion mitral annuloplasty, the LV is positively reshaped by the
oapsys device. This reduction of ventricular sphericity may
ave significant long-term consequences; progressive in-
reases in sphericity after reduction annuloplasty are associated
ith recurrent mitral insufficiency.16 Third, the reduction of
entricular volumes with the Coapsys device may indeed have
secondary role as a heart failure therapy, in addition to its
rimary role in the treatment of mitral insufficiency.
imitations
his study primarily deals with intraoperative dimensional
nd functional changes. The RESTOR-MV trial is ongoing
ith primary end points at 1 year and should provide
ong-term information regarding the geometric stability of
oth the degree of mitral insufficiency and ventricular re-
haping. Likewise, the potential clinical benefits of the ven-
ricular shape change will be evaluated, as well as the safety
rofile of the device.
onclusions
oth the Coapsys device and standard mitral annuloplasty
cutely reduce functional mitral insufficiency and annular
imension. The Coapsys device, however, provides signif-
cantly greater LV reshaping as compared with standard
itral annuloplasty. Further evaluation will assess the long-
erm valvular function and ventricular geometric stability
fter both techniques.
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